Advertisement

Topics

Mitsubishi Tanabe Buys NeuroDerm for $1.1 Bilion

07:26 EDT 28 Jul 2017 | CHEManager

Japanese drugmaker Mitsubishi Tanabe Pharma has agreed to acquire Israel’s NeuroDerm for around $1.1 billion in cash.

Original Article: Mitsubishi Tanabe Buys NeuroDerm for $1.1 Bilion

NEXT ARTICLE

More From BioPortfolio on "Mitsubishi Tanabe Buys NeuroDerm for $1.1 Bilion"

Quick Search
Advertisement